Literature DB >> 18757298

The antitumorigenic response of neural precursors depends on subventricular proliferation and age.

Joo-Hee Walzlein1, Michael Synowitz, Boris Engels, Darko S Markovic, Konrad Gabrusiewicz, Evgeni Nikolaev, Kazuaki Yoshikawa, Bozena Kaminska, Gerd Kempermann, Wolfgang Uckert, Leszek Kaczmarek, Helmut Kettenmann, Rainer Glass.   

Abstract

Glioblastomas, the most aggressive primary brain tumors, occur almost exclusively in adult patients. Neural precursor cells (NPCs) are antitumorigenic in mice, as they can migrate to glioblastomas and induce tumor cell death. Here, we show that the antitumor effect of NPCs is age-dependently controlled by cell proliferation in the subventricular zone (SVZ) and that NPCs accumulating at a glioblastoma are diverted from their normal migratory path to the olfactory bulb. Experimentally induced cortical glioblastomas resulted in decreased subventricular proliferation in adult (postnatal day 90) but not in young (postnatal day 30) mice. Adult mice supplied fewer NPCs to glioblastomas and had larger tumors than young mice. Apart from the difference in proliferation, there was neither a change in cell number and death rate in the SVZ nor a change in angiogenesis and immune cell density in the tumors. The ability to kill glioblastomas was similar in NPCs isolated from young and adult mice. The proliferative response of NPCs to glioblastomas depended on the expression of D-type cyclins. In young mice, NPCs express the cyclins D1 and D2, but the expression of cyclin D1 is lost during aging, and in adult NPCs only cyclin D2 remains. In young and adult cyclin D2-deficient mice we observed a reduced supply of NPCs to glioblastomas and the generation of larger tumors compared with wild-type mice. We conclude that cyclin D1 and D2 are nonredundant for the antitumor response of subventricular NPCs. Loss of a single D-type cyclin results in a smaller pool of proliferating NPCs, lower number of NPCs migrating to the tumor, and reduced antitumor activity. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757298     DOI: 10.1634/stemcells.2008-0307

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  18 in total

Review 1.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

2.  Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.

Authors:  Anne-Katrin Hickmann; Minou Nadji-Ohl; Nikolai J Hopf
Journal:  J Neurooncol       Date:  2015-01-04       Impact factor: 4.130

3.  Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.

Authors:  Omar Dzaye; Feng Hu; Katja Derkow; Verena Haage; Philipp Euskirchen; Christoph Harms; Seija Lehnardt; Michael Synowitz; Susanne A Wolf; Helmut Kettenmann
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-30       Impact factor: 3.685

Review 4.  Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions.

Authors:  R E Kast; B M Ellingson; C Marosi; M-E Halatsch
Journal:  J Neurooncol       Date:  2013-11-17       Impact factor: 4.130

5.  Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the niche.

Authors:  Felipe de Almeida Sassi; Algemir Lunardi Brunetto; Gilberto Schwartsmann; Rafael Roesler; Ana Lucia Abujamra
Journal:  J Oncol       Date:  2012-07-08       Impact factor: 4.375

6.  Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1.

Authors:  Kristin Stock; Jitender Kumar; Michael Synowitz; Stefania Petrosino; Roberta Imperatore; Ewan St J Smith; Peter Wend; Bettina Purfürst; Ulrike A Nuber; Ulf Gurok; Vitali Matyash; Joo-Hee Wälzlein; Sridhar R Chirasani; Gunnar Dittmar; Benjamin F Cravatt; Stefan Momma; Gary R Lewin; Alessia Ligresti; Luciano De Petrocellis; Luigia Cristino; Vincenzo Di Marzo; Helmut Kettenmann; Rainer Glass
Journal:  Nat Med       Date:  2012-07-22       Impact factor: 53.440

7.  Cellular host responses to gliomas.

Authors:  Joseph Najbauer; Peter C Huszthy; Michael E Barish; Elizabeth Garcia; Marianne Z Metz; Sarah M Myers; Margarita Gutova; Richard T Frank; Hrvoje Miletic; Stephen E Kendall; Carlotta A Glackin; Rolf Bjerkvig; Karen S Aboody
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

8.  Glioblastoma-initiating cells: relationship with neural stem cells and the micro-environment.

Authors:  Nicolas Goffart; Jérôme Kroonen; Bernard Rogister
Journal:  Cancers (Basel)       Date:  2013-08-14       Impact factor: 6.639

9.  Transmigration of neural stem cells across the blood brain barrier induced by glioma cells.

Authors:  Mónica Díaz-Coránguez; José Segovia; Adolfo López-Ornelas; Henry Puerta-Guardo; Juan Ludert; Bibiana Chávez; Noemi Meraz-Cruz; Lorenza González-Mariscal
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  A microRNA Link to Glioblastoma Heterogeneity.

Authors:  Sanjay K Singh; Alenoush Vartanian; Kelly Burrell; Gelareh Zadeh
Journal:  Cancers (Basel)       Date:  2012-09-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.